# Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

> **NCT05132699** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 21 (actual)

## Conditions studied

- Posttraumatic Stress Disorder
- Stress Disorders, Post-Traumatic

## Interventions

- **DRUG:** Cannabidiol (CBD) oral solution
- **DRUG:** Placebo
- **BEHAVIORAL:** Massed Prolonged Exposure (mPE)

## Key facts

- **NCT ID:** NCT05132699
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-04
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05132699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05132699, "Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05132699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*